Navigation Links
New research finds evidence of charitable behavior in bacteria
Date:9/1/2010

Researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard and from Boston University have discovered that charitable behavior exists in one of the most microscopic forms of lifebacteria. Their findings appear in the current issue of Nature.

In studying the development of antibiotic-resistant strains of bacteria, the researchers found that the populations most adept at withstanding doses of antibiotics are those in which a few highly resistant isolates sacrifice their own well being to improve the group's overall chance of survival.

This bacterial altruism results when the most resistant isolates produce a small molecule called indole.

Indole acts as something of a steroid, helping the strain's more vulnerable members bulk up enough to fight off the antibiotic onslaught. But while indole may save the group, its production takes a toll on the fitness level of the individual isolates that produce it.

"We weren't expecting to find this," said lead investigator James J. Collins, Ph.D., professor of Biomedical Engineering at Boston University, a core faculty member of the Wyss Institute, and a Howard Hughes Medical Institute investigator. "Typically, you would expect only the resistant strains to survive, with the susceptible ones dying off in the face of antibiotic stress. We were quite surprised to find the weak strains not only surviving, but thriving."

The findings also shed new light on the level of complexity and heterogeneity within bacterial strains. Until now, it was assumed that the overall resistance level of any given population was reflected in each of its isolates. Instead, Collins and his team found that dramatic differences can exist within a single population with some bacteria showing exceptional resistance and some almost none, not unlike cancer cells in humans.

The fact that the full complexity of bacteria strains can now be more accurately understood has significant ramifications for the medical community. "Now, when we measure the resistance in a population, we'll know that it may be tricking us," said Collins. "We'll know that even an isolate that shows no resistance can put up a stronger battle against antibiotics thanks to its buddies."

Collins is a founder of the field of synthetic biology, an area of research that combines science and engineering to construct new biological circuits that can reprogram organisms, particularly bacteria, to perform desired tasks, much like we program computers now.

His research at Boston University has also led to the development of a new class of medical devices being developed at the Wyss Institute, including vibrating insoles that help reduce falls among elderly users and normalize the gait of children with cerebral palsy.

"The Wyss Institute was founded on the premise that by breaking down institutional barriers and bringing together some of the world's top minds in science and engineering, we could accelerate transformative discovery," said Donald E. Ingber, M.D., Ph.D., Founding Director of the Wyss Institute. "I'm proud to say that the research being done by Dr. Collins is a great example of how this vision is beginning to play out."


'/>"/>

Contact: Mary Tolikas
mary.tolikas@wyss.harvard.edu
Wyss Institute for Biologically Inspired Engineering at Harvard
Source:Eurekalert

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. 2010 HSR Impact Award recognizes surgical safety research
3. MSU launches first anti-counterfeiting research program
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
8. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
9. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
10. International Diabetes Federation awards $2 million to 9 global diabetes research projects
11. Gladstones Robert Mahley to receive Research!America advocacy award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... philanthropic community at its 10th anniversary Fashion Luncheon on Monday, February 8, 2016. ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... life cycle of pharmaceutical products, garnering increased attention from all stakeholders in the ...
(Date:2/12/2016)... ... , ... As a former television executive, owner Tal Rabinowitz knows how stressful ... decompress, Rabinowitz found herself drawn to a casual meditation class while working at NBC ... implementing a 20-minute-per-day meditation practice with her team. After her tenure at NBC, she ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., ... have closed for the ISE Southeast Awards 2016. Finalists and winners of the ... ISE® Southeast Executive Forum and Awards Gala on March 15, 2016 at the ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... a Service (WaaS), today announced the integration of Clarity Intelligence Platform (CIP) into ... partners to offer real-time business intelligence (BI) to their small and medium business ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , 12 februari 2016 AAIPharma ... toonaangevende leverancier van productie en ontwikkeling op ... kondigt vandaag een uitbreiding aan van steriele ... locatie in Charleston, SC ... tot meerdere recente investeringen. http://photos.prnewswire.com/prnh/20150806/256637LOGO ...
(Date:2/12/2016)... February 12, 2016 ... titled Chronic Inflammation Global Clinical Trials Review, H2, ... the global clinical trials landscape along with top ... Region, Country (G7 & E7), Trial Status, Trial ... reviews top companies involved and enlists all trials ...
(Date:2/11/2016)... , Feb. 11, 2016 Stem cells ... are characterized by self-renewal and the capacity to differentiate ... relatively new discovery, as the first mouse embryonic stem ... was not until 1995 that the first culturing of ... stem cells were not produced until 2006 As a ...
Breaking Medicine Technology: